Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tema

Trastornos del movimiento Enfermedad de Parkinson Distonía Corea y enfermedad de Huntington Ataxia Temblor y temblor esencial Mioclonía y espasmos Tics y síndrome de Tourette Síndrome de piernas inquietas Síndrome de la persona rígida Alteraciones de la marcha Espasticidad COVID-19 y Enfermedades Neurológicas

Año

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Neurotoxic in vivo models of Parkinson's disease recent advances.

Cannon JR, Greenamyre JT.

Prog Brain Res. 2010;184:17-33. doi: 10.1016/S0079-6123(10)84002-6. Review.

PUBMED

A case series of peripheral neuropathy in patients with Parkinson's disease.

Gondim Fde A, de Oliveira GR, Peixoto AA Jr, Horta WG.

Ann Neurol. 2010 Dec;68(6):973-5; author reply 975. doi: 10.1002/ana.22258. No abstract available.

PUBMED

Fatigue in Parkinson's disease: prevalence and associated factors.

Beiske AG, Loge JH, Hjermstad MJ, Svensson E.

Mov Disord. 2010 Oct 30;25(14):2456-60. doi: 10.1002/mds.23372.

PUBMED

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies.

Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ.

J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):215-21. doi: 10.1136/jnnp.2009.175463.

PUBMED

Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases.

Soilu-Hänninen M, Broberg E, Röyttä M, Mattila P, Rinne J, Hukkanen V.

Acta Neurol Scand. 2010 Jan;121(1):44-50. doi: 10.1111/j.1600-0404.2009.01179.x.

PUBMED

Enhanced frontal function in Parkinson's disease.

Cools R, Miyakawa A, Sheridan M, D'Esposito M.

Brain. 2010 Jan;133(Pt 1):225-33. doi: 10.1093/brain/awp301.

PUBMED

Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells.

Ortiz-Ortiz MA, Morán JM, Ruiz-Mesa LM, Niso-Santano M, Bravo-SanPedro JM, Gómez-Sánchez R, González-Polo RA, Fuentes JM.

Neurosci Lett. 2010 Jan 4;468(2):120-4. doi: 10.1016/j.neulet.2009.10.081.

PUBMED

Background scenery visual hallucinations in a depressed patient with Parkinson's disease.

Kataoka H, Inoue M, Ueno S.

Mov Disord. 2010 Apr 30;25(6):786-7. doi: 10.1002/mds.23004. No abstract available.

PUBMED

A clinical maneuver to increase tremor differentiation between Parkinson disease and essential tremor.

Mazzocchio R, Rossi A.

Eur J Neurol. 2010 Sep;17(9):e89. doi: 10.1111/j.1468-1331.2010.03121.x. No abstract available.

PUBMED

Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.

Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, Le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM.

Hum Mutat. 2010 May;31(5):561-8. doi: 10.1002/humu.21225.

PUBMED

Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations.

Buck PO, Trautman H, Clark J.

Int J Neurosci. 2010 Aug;120(8):523-30. doi: 10.3109/00207454.2010.489725. Review.

PUBMED

A trojan horse for Parkinson's disease.

Hu Y, Tong Y.

Sci Signal. 2010 Apr 6;3(116):pe13. doi: 10.1126/scisignal.3116pe13. Review.

PUBMED

Parkinson's disease: oxidative stress and therapeutic approaches.

Surendran S, Rajasankar S.